Every 8-K that GMRBV (GMRBV) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow GMRBV and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full GMRBV filings page.
Chiron Real Estate Inc. expanded its senior housing portfolio by closing two acquisitions in Alexandria, Virginia. It bought The Landing Alexandria for $130 million and The Riviera Alexandria for $118.9 million, and will operate both as senior housing operating property assets under third‑party management by Greystone Communities.
To support these deals, the company completed a private placement of 1,000,000 shares of 6.00% Series C Convertible Preferred Stock at $100.00 per share for gross proceeds of about $100,000,000, and incurred approximately $147 million of additional borrowings under its Third Amended and Restated Credit Facility. It designated 1,000,000 shares as Series C Convertible Preferred Stock and created economically similar Series C Convertible Preferred Units at the operating partnership level, with new distribution restrictions applying if preferred distributions are not declared.
Chiron Real Estate Inc. reported several governance and capital actions from its 2026 annual meeting. The Board expanded from six to seven members and appointed Charles Fitzgerald as a director, with service through the 2027 annual meeting and committee roles on Compensation and Nominating and Corporate Governance.
Stockholders approved an amendment to the 2016 Equity Incentive Plan, extending its term to May 20, 2036 and increasing shares reserved for issuance by 300,000. They also approved, on an advisory basis, executive compensation and ratified Deloitte & Touche LLP as independent auditor for 2026.
In a related press release, Chiron highlighted that Mr. Fitzgerald holds 97,293 shares of its common stock via affiliated entities, and announced second quarter 2026 preferred dividends: $0.46875 per share on Series A and $0.50 per share on Series B, both payable July 31, 2026 to holders of record on July 15, 2026.
Chiron Real Estate Inc. entered into an investment agreement with Maewyn XRN LP and other purchasers for a private placement of up to $100.0 million of new 6.00% Series C Convertible Perpetual Preferred Stock.
The company may sell up to 1,000,000 Series C shares at $100.00 per share in tranches, with an initial funding of at least $25.0 million expected to close on or before June 20, 2026. The preferred stock carries a 6.00% cash dividend that can step up over time, ranks senior to common stock, and is convertible into common stock at an initial implied price of $43.00 per share, subject to anti-dilution and 19.9% ownership caps before stockholder approval.
Chiron will pay a 3% commitment fee on the $100.0 million commitment and reimburse up to $250,000 of investor legal fees, and expects to use proceeds for general business, working capital and potential acquisitions. Maewyn receives board nomination, consent and standstill rights, while holders gain registration rights and warrants in certain redemption scenarios.
Chiron Real Estate Inc. is reshaping itself into a growth-focused healthcare REIT, pairing large senior housing investments with new strategic capital and a lower dividend. The company agreed to acquire three luxury seniors housing communities from Silverstone for an aggregate $425 million, to be operated as seniors housing operating properties (SHOP) and managed by Greystone. It also entered into a $100 million delayed-draw 6.00% Series C convertible preferred equity facility with Maewyn Capital Partners, with an initial conversion price of $43.00 per common share.
To retain more cash for growth, the Board reset the monthly common dividend to $0.16 per share for July–September 2026, a quarterly total of $0.48 versus $0.75 for April–June, an approximate 36% reduction. For the quarter ended March 31, 2026, rental revenue was $38.0 million, net income was $1.7 million and net loss attributable to common stockholders was $0.7 million, or $(0.06) per share. Core FFO was $16.0 million, or $1.11 per share and unit, flat year over year, while same-property cash NOI rose 3.2% and leased occupancy was 95.4%. Net consolidated debt was about $664.9 million and the company reported no debt maturities in 2026 or 2027, with $220.5 million of credit facility borrowing capacity as of May 5, 2026.
Chiron Real Estate Inc. entered into a Master Note and Guaranty Agreement with NYL Investors LLC and certain affiliates, creating an uncommitted senior note facility for its operating partnership. The facility permits issuance of senior unsecured notes in one or more series with an aggregate outstanding principal of up to $150.0 million.
Notes may be issued for up to three years from the agreement’s effective date, subject to earlier termination events, and each series will mature within ten years of issuance. Each issuance must be at least $10.0 million, with interest set at issuance as a spread over U.S. Treasuries and paid quarterly or semi-annually. The operating partnership may prepay the notes, subject to a customary make-whole amount, and the notes rank equally with its other senior unsecured debt.
Chiron Real Estate Inc., formerly Global Medical REIT, reported 2025 results, updated its capital strategy and completed a corporate rebrand. For 2025, total revenue was $148.2 million and the company recorded a net loss of $6.9 million, driven in part by $13.0 million of property impairments.
FFO attributable to common stockholders and noncontrolling interest was $57.6 million ($3.97 per share and unit), while Core FFO reached $65.8 million ($4.53 per share and unit). Leverage was 44.4% at December 31, 2025, with $653.9 million of consolidated debt at a 3.74% weighted average interest rate and no maturities in 2026 or 2027.
The board kept the annualized common dividend at $3.00 per share but shifted to monthly payments, declaring $0.25 per share for each of April, May and June 2026. The company invested $7.1 million for a 49% interest in an active adult joint venture and set 2026 Core FFO guidance at $4.30 to $4.45 per share and unit. A key tenant, White Rock Medical Center, filed for Chapter 11, and Chiron carried a $1.4 million net receivable from its support efforts.
Global Medical REIT Inc. reported that director Henry Cole has informed the Board that he intends to step down as a director, effective at the Company’s 2026 Annual Meeting of Stockholders. He will not be nominated for re-election, and his service will end when his current term expires on the date of that meeting.
The Company states that Mr. Cole’s decision to step down is not due to any disagreement with Global Medical REIT Inc. on matters related to its operations, policies, or practices, indicating an orderly and planned board transition rather than a dispute-driven change.
Global Medical REIT Inc. reported that director Ronald Marston has informed the Board that he intends to retire as a director, effective at the company’s 2026 Annual Meeting of Stockholders. He will not stand for re-election, and his service will conclude when his current term expires at that meeting. The company stated that Mr. Marston’s decision to retire is not due to any disagreement with Global Medical REIT regarding its operations, policies, or practices, indicating this is a planned governance transition rather than a response to a specific dispute.